Terms: = Brain cancer AND CARS, P49589, 833, ENSG00000110619 AND Diagnosis
19 results:
1. Raman Spectroscopy as a Tool to Study the Pathophysiology of brain Diseases.
Terrones O; Olazar-Intxausti J; Anso I; Lorizate M; Nieto-Garai JA; Contreras FX
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768712
[TBL] [Abstract] [Full Text] [Related]
2. MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients.
Ferrer VP
Cancer Genet; 2023 Jan; 270-271():22-30. PubMed ID: 36436416
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic yield of diffusion-weighted brain MR imaging in patients with cognitive impairment: Large cohort study with 3,298 patients.
Kim M; Kim SY; Suh CH; Shim WH; Lee JH; Guenette JP; Huang RY; Kim SJ
PLoS One; 2022; 17(9):e0274795. PubMed ID: 36136975
[TBL] [Abstract] [Full Text] [Related]
4. MTDCNet: A 3D multi-threading dilated convolutional network for brain tumor automatic segmentation.
Chen W; Zhou W; Zhu L; Cao Y; Gu H; Yu B
J Biomed Inform; 2022 Sep; 133():104173. PubMed ID: 35998815
[TBL] [Abstract] [Full Text] [Related]
5. The role of frailty in the clinical management of neurofibromatosis type 1: a mixed-effects modeling study using the Nationwide Readmissions Database.
Shahrestani S; Brown NJ; Strickland BA; Bakhsheshian J; Ghodsi SM; Nasrollahi T; Borrelli M; Gendreau J; Ruzevick JJ; Zada G
Neurosurg Focus; 2022 May; 52(5):E3. PubMed ID: 35535825
[TBL] [Abstract] [Full Text] [Related]
6. 18F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study.
Mišir Krpan A; Hodolič M; Golubić AT; Baučić M; Nemir J; Mrak G; Žuvić M; Huić D
Croat Med J; 2021 Aug; 62(4):310-317. PubMed ID: 34472733
[TBL] [Abstract] [Full Text] [Related]
7. Label-free brain tumor imaging using Raman-based methods.
Hollon T; Orringer DA
J Neurooncol; 2021 Feb; 151(3):393-402. PubMed ID: 33611706
[TBL] [Abstract] [Full Text] [Related]
8. Visual search errors are persistent in a laboratory analog of the incidental finding problem.
Nartker MS; Alaoui-Soce A; Wolfe JM
Cogn Res Princ Implic; 2020 Jul; 5(1):32. PubMed ID: 32728864
[TBL] [Abstract] [Full Text] [Related]
9. Improving Timeliness of Lung cancer diagnosis and Staging Investigations Through Implementation of Standardized Triage Pathways.
Mullin MLL; Tran A; Golemiec B; Stone CJL; Noseworthy C; O'Callaghan N; Parker CM; Digby GC
JCO Oncol Pract; 2020 Oct; 16(10):e1202-e1208. PubMed ID: 32639927
[TBL] [Abstract] [Full Text] [Related]
10. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma.
Wang J; Che F; Zhang J; Zhang M; Xiao S; Liu Y; Zhou L; Su Q; You C; Lu Y; Heng X
World Neurosurg; 2019 May; 125():e1217-e1225. PubMed ID: 30794970
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of cardiopulmonary ultrasound in elderly patients with acute respiratory distress syndrome.
Huang D; Ma H; Xiao Z; Blaivas M; Chen Y; Wen J; Guo W; Liang J; Liao X; Wang Z; Li H; Li J; Chao Y; Wang XT; Wu Y; Qin T; Su K; Wang S; Tan N
BMC Pulm Med; 2018 Aug; 18(1):136. PubMed ID: 30103730
[TBL] [Abstract] [Full Text] [Related]
13. HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
Ahmed N; Brawley V; Hegde M; Bielamowicz K; Kalra M; Landi D; Robertson C; Gray TL; Diouf O; Wakefield A; Ghazi A; Gerken C; Yi Z; Ashoori A; Wu MF; Liu H; Rooney C; Dotti G; Gee A; Su J; Kew Y; Baskin D; Zhang YJ; New P; Grilley B; Stojakovic M; Hicks J; Powell SZ; Brenner MK; Heslop HE; Grossman R; Wels WS; Gottschalk S
JAMA Oncol; 2017 Aug; 3(8):1094-1101. PubMed ID: 28426845
[TBL] [Abstract] [Full Text] [Related]
14. Management of pediatric intracranial low-grade gliomas: long-term follow-up after radiation therapy.
Huynh-Le MP; Walker AJ; Burger PC; Jallo GI; Cohen KJ; Wharam MD; Terezakis SA
Childs Nerv Syst; 2016 Aug; 32(8):1425-30. PubMed ID: 27179530
[TBL] [Abstract] [Full Text] [Related]
15. Socio-economic characteristics of patients with glioblastoma multiforme.
Muquit S; Parks R; Basu S
J Neurooncol; 2015 Nov; 125(2):325-9. PubMed ID: 26334316
[TBL] [Abstract] [Full Text] [Related]
16. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
Morgan RA; Johnson LA; Davis JL; Zheng Z; Woolard KD; Reap EA; Feldman SA; Chinnasamy N; Kuan CT; Song H; Zhang W; Fine HA; Rosenberg SA
Hum Gene Ther; 2012 Oct; 23(10):1043-53. PubMed ID: 22780919
[TBL] [Abstract] [Full Text] [Related]
17. 1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.
Gozé C; Bezzina C; Gozé E; Rigau V; Maudelonde T; Bauchet L; Duffau H
J Neurooncol; 2012 May; 108(1):69-75. PubMed ID: 22392125
[TBL] [Abstract] [Full Text] [Related]
18. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract] [Full Text] [Related]
19. Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function.
Sibal L; Ugwu P; Kendall-Taylor P; Ball SG; James RA; Pearce SH; Hall K; Quinton R
Pituitary; 2002; 5(4):243-6. PubMed ID: 14558672
[TBL] [Abstract] [Full Text] [Related]
